List of Zoladex drug patents

Zoladex is owned by Tersera.

Zoladex contains Goserelin Acetate.

Zoladex has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Zoladex are:

  • US7220247
  • US7118552

Zoladex was authorised for market use on 29 December, 1989.

Zoladex is available in implant;implantation dosage forms.

The generics of Zoladex are possible to be released after 13 April, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7220247 TERSERA Automatically operable safety shield system for syringes
Apr, 2022

(11 months ago)

US7118552 TERSERA Automatically operable safety shield system for syringes
Apr, 2022

(11 months ago)

Drugs and Companies using GOSERELIN ACETATE ingredient

Market Authorisation Date: 29 December, 1989

Treatment: NA

Dosage: IMPLANT;IMPLANTATION

More Information on Dosage

ZOLADEX family patents

4

Japan

3

United States

2

United Kingdom

1

Portugal

1

Germany

1

Malaysia

1

Russia

1

Spain

1

Brazil

1

Colombia

1

New Zealand

1

Estonia

1

Norway

1

Argentina

1

Austria

1

Mexico

1

China

1

Taiwan, Province of China

1

Korea, Republic of

1

Hong Kong

1

South Africa

1

Slovakia

1

Canada

1

Cyprus

1

Slovenia

1

Bulgaria

1

Hungary

1

Ukraine

1

Czech Republic

1

Israel

1

Iceland

1

Poland

1

Australia

1

Denmark

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic